Why the study?
Do oral antithrombotic agents prevent stroke in adults with nonvalvular atrial fibrillation?
Do oral antithrombotic agents prevent stroke in adults with nonvalvular atrial fibrillation?
Stratification of stroke risk is important when using oral antithrombotic agents for stroke prevention in nonvalvular atrial fibrillation due to the major risk of bleeding.
Answers are grounded in this paper and cite their sources.
Requires careful bleeding risk assessment with antithrombotics in nonvalvular AF; leaves open optimal agent selection in high-risk subgroups.
T he rate of stroke among adults with atrial fibrilla- tion (AF) varies widely, ranging between 1% and 20% annually (mean 4.5% per year) depending on comorbidities and a patient's history of prior cerebrovascular events. 1 Stratification of stroke risk is important, because the major risk of antithrombotic medications used to lower the incidence of AF-related stroke is bleeding. 2]
No takes yet. Share an insight, caveat, or question.
Furie et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: